Sultan Abdel-Rahman

1.6k total citations · 1 hit paper
16 papers, 960 citations indexed

About

Sultan Abdel-Rahman is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Oncology. According to data from OpenAlex, Sultan Abdel-Rahman has authored 16 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Biomedical Engineering and 7 papers in Oncology. Recurrent topics in Sultan Abdel-Rahman's work include Sarcoma Diagnosis and Treatment (9 papers), Ultrasound and Hyperthermia Applications (9 papers) and Neuroblastoma Research and Treatments (3 papers). Sultan Abdel-Rahman is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), Ultrasound and Hyperthermia Applications (9 papers) and Neuroblastoma Research and Treatments (3 papers). Sultan Abdel-Rahman collaborates with scholars based in Germany, Switzerland and Netherlands. Sultan Abdel-Rahman's co-authors include Rolf D. Issels, Lars H. Lindner, Wolfgang Hiddemann, Christoph Salat, Rüdiger Wessalowski, Ulrich Mansmann, Karl‐Walter Jauch, Peter Hohenberger, Clemens‐Martin Wendtner and Hans Roland Dürr and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and The Lancet Oncology.

In The Last Decade

Sultan Abdel-Rahman

16 papers receiving 943 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study

2010 486 citations Rolf D. Issels, Lars H. Lindner et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Sultan Abdel-Rahman

Since Specialization

Citations

This map shows the geographic impact of Sultan Abdel-Rahman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sultan Abdel-Rahman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sultan Abdel-Rahman more than expected).

Fields of papers citing papers by Sultan Abdel-Rahman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sultan Abdel-Rahman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sultan Abdel-Rahman. The network helps show where Sultan Abdel-Rahman may publish in the future.

Co-authorship network of co-authors of Sultan Abdel-Rahman

This figure shows the co-authorship network connecting the top 25 collaborators of Sultan Abdel-Rahman. A scholar is included among the top collaborators of Sultan Abdel-Rahman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sultan Abdel-Rahman. Sultan Abdel-Rahman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinoma 2025 ·Cancer Immunology Immunotherapy ·(unknown), (unknown), Axel Lechner, (unknown), (unknown), Sultan Abdel-Rahman, (unknown), Wolfgang G. Kunz, Thomas Knösel, Martin Canis, Michael von Bergwelt‐Baildon, Rolf D. Issels, Dorit Di Gioia, Lars H. Lindner	1
2	Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial 2021 ·European Journal of Cancer ·Rolf D. Issels, Elfriede Noeßner, Lars H. Lindner, M. Schmidt, Markus Albertsmeier, Jean‐Yves Blay, Emanuel Stutz, Yujun Xu, Veit Buecklein, A. Altendorf-Hofmann, Sultan Abdel-Rahman, Ulrich Mansmann, Michael von Bergwelt‐Baildon, (unknown)	16
3	Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer 2021 ·Cancers ·Oliver J. Ott, Cihan Gani, Lars H. Lindner, Manfred Schmidt, Ulf Lamprecht, Sultan Abdel-Rahman, Axel Hinke, Thomas Weißmann, Arndt Hartmann, Rolf D. Issels, Daniel Zips, Claus Belka, Robert Grützmann, Rainer Fietkau	18
4	Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience 2020 ·Breast Care ·Oliver J. Stoetzer, Dorit Di Gioia, Rolf D. Issels, Sultan Abdel-Rahman, Ulrich Mansmann, Lars H. Lindner, Oleg Gluz, Rachel Würstlein, Michael Braun, Moritz Hamann, Franz Edler von Koch, Nadia Harbeck, Christoph Salat	4
5	Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma 2020 ·Sarcoma ·Veit Bücklein, (unknown), Eric Kampmann, Gesa Schuebbe, Rolf D. Issels, Falk Roeder, Martin K. Angele, Hans Roland Dürr, Thomas Knösel, Sultan Abdel-Rahman, Dorit Di Gioia, Lars H. Lindner	6
6	Quality assurance guidelines for superficial hyperthermia clinical trials 2017 ·Strahlentherapie und Onkologie ·Hana Dobšíček Trefná, Johannes Crezee, Manfred Schmidt, Dietmar Marder, Ulf Lamprecht, Michael Ehmann, Jacek Nadobny, Josefin Hartmann, (unknown), Sultan Abdel-Rahman, Sergio Curto, A. Bakker, Mark Hurwitz, Chris J. Diederich, Paul R. Stauffer, Gerard C. van Rhoon	76
7	Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirements 2017 ·International Journal of Hyperthermia ·Hana Dobšíček Trefná, Johannes Crezee, Manfred Schmidt, Dietmar Marder, Ulf Lamprecht, Michael Ehmann, Josefin Hartmann, Jacek Nadobny, Johanna Gellermann, (unknown), Pirus Ghadjar, N. Lomax, Sultan Abdel-Rahman, Christoph Bert, A. Bakker, Mark Hurwitz, Chris J. Diederich, Paul R. Stauffer, Gerard C. van Rhoon	83
8	CT fluoroscopy-guided closed-tip catheter placement before regional hyperthermia treatment of soft tissue sarcomas: 5-Year experience in 35 consecutive patients 2015 ·International Journal of Hyperthermia ·Frederik F. Strobl, (unknown), (unknown), (unknown), Tobias Geith, Sultan Abdel-Rahman, (unknown), Lars H. Lindner, Maximilian F. Reiser, Christoph Trumm	3
9	Concomitant Trimodality Therapy of Re-irradiation, Chemotherapy and Regional Hyperthermia for a Pretreated Inoperable Sarcoma Recurrence 2015 ·Tumori Journal ·Minglun Li, (unknown), Maximilian Niyazi, Rolf D. Issels, Sultan Abdel-Rahman, (unknown), Farkhad Manapov	2
10	Effectiveness of Regional Hyperthermia With Chemotherapy for High-Risk Retroperitoneal and Abdominal Soft-Tissue Sarcoma After Complete Surgical Resection 2014 ·Annals of Surgery ·Martin K. Angele, Markus Albertsmeier, (unknown), Peter Hohenberger, Sultan Abdel-Rahman, (unknown), M. Schmidt, Ulrich Mansmann, Christiane J. Bruns, Rolf D. Issels, Karl‐Walter Jauch, Lars H. Lindner	45
11	Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer 2012 ·International Journal of Hyperthermia ·(unknown), Valeria Milani, Frank Berger, (unknown), Sultan Abdel-Rahman, Christoph Salat, Rolf D. Issels	35
12	Quality assurance for clinical studies in regional deep hyperthermia 2011 ·Strahlentherapie und Onkologie ·G. Bruggmoser, (unknown), Richard Canters, Johannes Crezee, Michael Ehmann, Johanna Gellermann, Ulf Lamprecht, N. Lomax, (unknown), Oliver J. Ott, Sultan Abdel-Rahman, Rolf Sauer, Manfred Schmidt, Andreas Thomsen, Rüdiger Wessalowski, Gerard C. van Rhoon	87
13	Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study breakdown → 2010 ·The Lancet Oncology ·Rolf D. Issels, Lars H. Lindner, Jaap Verweij, Peter Wust, Peter Reichardt, Baard‐Christian Schem, Sultan Abdel-Rahman, Soeren Daugaard, Christoph Salat, Clemens‐Martin Wendtner, Željko Vujašković, Rüdiger Wessalowski, Karl‐Walter Jauch, Hans Roland Dürr, Ferdinand Ploner, Andrea Baur‐Melnyk, Ulrich Mansmann, Wolfgang Hiddemann, Jean‐Yves Blay, Peter Hohenberger	486
14	Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS) 2009 ·International Journal of Hyperthermia ·Robert Stahl, Tungte Wang, Lars H. Lindner, Sultan Abdel-Rahman, (unknown), Maximilian F. Reiser, Rolf D. Issels	16
15	Efficacy of Consolidation High-Dose Chemotherapy with Ifosfamide, Carboplatin and Etoposide (HD-ICE) Followed by Autologous Peripheral Blood Stem Cell Rescue in Chemosensitive Patients with Metastatic Soft Tissue Sarcomas 2006 ·Oncology ·M. Schlemmer, Clemens‐Martin Wendtner, Martin Falk, Sultan Abdel-Rahman, Thomas Licht, Jens Baumert, Christian Straka, Marcus Hentrich, Christoph Salat, Wolfgang Hiddemann, Rolf D. Issels	14
16	Response to Neoadjuvant Chemotherapy Combined With Regional Hyperthermia Predicts Long-Term Survival for Adult Patients With Retroperitoneal and Visceral High-Risk Soft Tissue Sarcomas 2002 ·Journal of Clinical Oncology ·Clemens-M. Wendtner, Sultan Abdel-Rahman, (unknown), Jens Baumert, Lars H. Lindner, Andrea Baur, Wolfgang Hiddemann, Rolf D. Issels	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact